Dr. Parthasarathy Chandrakesan is an Assistant Professor in the Department of Medicine and Associate member in Oklahoma Cancer Center at University of Oklahoma Health Sciences Center, USA. Dr. Parthasarathy Chandrakesan has a broad background in Stem cell biology, Cancer marker characterization and therapeutics, Gastroenterology and Endocrinology with extensive training and experience in molecular and cellular biology and animal models relevant to the background knowledge. His major research focus is on experimental therapeutics using novel nanotechnology and ADC combination therapies for cancer treatment. Dr. Chandrakesan involved in evaluating lots of scientific minds by reviewing scientific articles and grants at National and International levels. He is member of the American Association of Cancer Research and member of American Gastroenterological Association.
Developing targeted therapies using novel nanotechnology and ADC combination machinery for Pancreatic, Breast and Colon cancers; Characterizing of cancer stem cells anddeveloping noveltreatment strategies to reduce recurrence; Signaling machinery and miRNA deviations as new targets to enhance the sensitivity of cancer cells and cancer stem cells for chemotherapy.